Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BACE2 antibody (N-Term)

This anti-BACE2 antibody is a Rabbit Polyclonal antibody detecting BACE2 in WB, IHC (p) and EIA. Suitable for Human, Rat and Mouse.
Catalog No. ABIN499395

Quick Overview for BACE2 antibody (N-Term) (ABIN499395)

Target

See all BACE2 Antibodies
BACE2 (beta-Site APP-Cleaving Enzyme 2 (BACE2))

Reactivity

  • 47
  • 35
  • 12
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Rat, Mouse

Host

  • 69
  • 3
  • 1
Rabbit

Clonality

  • 71
  • 2
Polyclonal

Conjugate

  • 34
  • 12
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BACE2 antibody is un-conjugated

Application

  • 54
  • 30
  • 28
  • 13
  • 13
  • 11
  • 11
  • 8
  • 8
  • 4
  • 3
  • 3
  • 2
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
  • Binding Specificity

    • 15
    • 8
    • 7
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Specificity

    BACE2 antibody was raised against a synthetic peptide corresponding to amino acids 44 to 59 of human BACE2.

    Purification

    Affinity chromatography purified via peptide column

    Immunogen

    Human BACE2 (N-Terminus) Peptide

    Isotype

    IgG
  • Application Notes

    ELISA. Western Blot: BACE2 can be used for detection of BACE2 at 0.5 to 1 μg/mL. Immunohistochemistry.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Buffer

    PBS containing 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store the antibody undiluted at 2-8 °C.
  • Target

    BACE2 (beta-Site APP-Cleaving Enzyme 2 (BACE2))

    Alternative Name

    BACE2

    Background

    Accumulation of the amyloid-beta (alphabeta) plaque in the cerebral cortex is a critical event in the pathogenesis of Alzheimer's disease. alphabeta peptide is generated by proteolytic cleavage of the beta-amyloid protein precursor (APP) at beta- and gamma-sites by proteases. The long-sought beta-secretase was recently identified by several groups independently and designated beta-site APP cleaving enzyme (BACE) and aspartyl protease 2 (Asp2) (1-4). A BACE homolog was recently cloned and designated BACE2, Asp1, DRAP (for Down region aspartic protease), and memapsin 1 (4-9). BACE2 also cleaves APP at beta-site and at a different site within alphabeta (8). BACE2 locates on chromosome 21q22.3, the so-called 'Down critical region', suggesting that BACE2 and alphabeta may also contribute to the pathogenesis of Down syndrome (6,7)Synonyms: AEPLC, ALP56, ASP1, ASP21, Aspartic-like protease 56 kDa, Aspartyl protease 1, Beta-secretase 2, Beta-site APP-cleaving enzyme 2, Down region aspartic protease, Memapsin-1, Membrane-associated aspartic protease 1

    Gene ID

    25825

    UniProt

    Q9Y5Z0
You are here:
Chat with us!